Skip to content
Menu

Petros Pharmaceuticals, Inc. PTPI

Full chart Compare
Set alert

Price alert · PTPI

All alert types
0.00 USD 0.00 (+0.00%)

As ofNov 16, 2026, 1:11 PM EST

0.0026 Day range 0.0026
0.002 52-week range 0.016
YTD
-67.50%
1 year
-84.71%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Other Income$3.36MGross Profit$3.90MNet Loss$14.32MCost of Revenue$1.21MExpenses$21.58MSelling, General & Admin$8.75MResearch & Development$2.62MOther Operating Expenses$10.21MRevenue$5.11MUnited States$4.04MNon-US$1.07M

Latest period ending Dec 31, 2024 · select a line to chart its full history

PTPI annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
5.11M5.82M5.99M7.81M9.56M
3.90M4.19M3.70M6.21M5.51M
-17.68M-10.76M-19.92M-18.05M-17.28M
-14.32M-8.16M-20.04M-8.99M-20.59M
-83.50-158.75-242.00-206.25-962.50
PTPI annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
1.72M13.34M9.43M23.85M17.14M
10.64M33.80M32.42M67.39M69.85M
18.10M21.32M15.72M31.85M52.38M
-7.47M12.07M16.70M35.54M17.47M
PTPI annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-2.60M-7.63M-12.80M-11.86M-15.31M
-24.59K000-4.63K
-7.00M11.54M-1.62M18.57M30.30M
-24.59K000-4.63K
-9.63M3.91M-14.42M6.71M14.99M